MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-22-2025
IQVIA Holdings Depreciation & Amortization 2011-2026 | IQV
Annual Depreciation & Amortization IQVIA Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.11 B | 1.12 B | 1.13 B | 1.26 B | 1.29 B | 1.2 B | 1.14 B | 1.01 B | 289 M | 128 M | 121 M | 108 M | 98.3 M | 92 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.29 B | 92 M | 722 M |
Quarterly Depreciation & Amortization IQVIA Holdings
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 276 M | 265 M | - | 278 M | 269 M | 264 M | - | 297 M | 259 M | 253 M | - | 248 M | 270 M | 255 M | - | 336 M | 343 M | 323 M | - | 319 M | 308 M | 316 M | - | 299 M | 294 M | 295 M | - | 283 M | 282 M | 282 M | - | 256 M | 245 M | 232 M | - | 34 M | 32 M | 32 M | - | 32.9 M | 30 M | 30.3 M | - | 30.2 M | 29.8 M | 29.1 M | - | 27.3 M | 25 M | 24.6 M | - | 25.7 M | 23.7 M | 23.3 M | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 343 M | 23.3 M | 190 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
47.8 M | $ 23.0 | 2.86 % | $ 248 M |  China |
 |
Castle Biosciences
CSTL
|
16 M | $ 39.93 | -1.67 % | $ 1.11 B | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
DarioHealth Corp.
DRIO
|
473 K | $ 12.98 | 6.97 % | $ 368 M |  Israel |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 27.9 | -0.39 % | $ 844 M | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
BioNano Genomics
BNGO
|
14 M | $ 1.6 | -0.22 % | $ 2.03 M | USA |
 |
Co-Diagnostics
CODX
|
1.23 M | $ 6.1 | 1.16 % | $ 179 M | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Danaher Corporation
DHR
|
721 M | $ 234.99 | -0.25 % | $ 172 B | USA |
 |
DexCom
DXCM
|
186 M | $ 68.47 | -2.33 % | $ 26.4 B | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | China |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
120 M | $ 101.77 | 0.14 % | $ 18.9 B | USA |
 |
Mettler-Toledo International
MTD
|
50.4 M | $ 1 461.94 | -0.56 % | $ 31 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
61.2 M | $ 6.63 | -0.08 % | $ 601 M | USA |
 |
CareDx, Inc
CDNA
|
14.4 M | $ 17.5 | -7.41 % | $ 941 M | USA |
 |
National Research Corporation
NRC
|
140 K | $ 19.66 | 4.02 % | $ 482 M | USA |
 |
Celcuity
CELC
|
130 K | $ 105.54 | -3.33 % | $ 4.16 B | USA |
 |
Natera
NTRA
|
16.7 M | $ 237.86 | -6.5 % | $ 23.4 B | USA |
 |
OPKO Health
OPK
|
98.2 M | $ 1.37 | 0.37 % | $ 951 M | USA |
 |
Anixa Biosciences
ANIX
|
38.3 K | $ 3.4 | 3.66 % | $ 108 K | USA |
 |
Guardant Health
GH
|
42.4 M | $ 107.75 | -1.98 % | $ 13.2 B | USA |
 |
Personalis
PSNL
|
10.9 M | $ 8.36 | -10.64 % | $ 495 M | USA |
 |
QIAGEN N.V.
QGEN
|
203 M | $ 48.19 | 1.71 % | $ 10.7 B |  Niderland |
 |
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
354 M | $ 146.41 | -2.48 % | $ 23.3 B | USA |
 |
Charles River Laboratories International
CRL
|
362 M | $ 214.0 | -1.51 % | $ 11 B | USA |
 |
Thermo Fisher Scientific
TMO
|
1.16 B | $ 605.45 | -1.87 % | $ 231 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
493 M | $ 177.06 | -0.64 % | $ 19.7 B | USA |
|
Biodesix
BDSX
|
5.77 M | $ 5.77 | -3.27 % | $ 748 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
644 M | $ 254.76 | 0.43 % | $ 21.4 B | USA |
 |
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
24.9 M | $ 34.81 | -4.76 % | $ 2.08 B | USA |
 |
ICON Public Limited Company
ICLR
|
488 M | $ 189.39 | -6.67 % | $ 15.6 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
130 M | $ 708.9 | -0.79 % | $ 58.5 B | USA |
 |
Lantheus Holdings
LNTH
|
64.6 M | $ 68.27 | -1.59 % | $ 4.72 B | USA |